Table 1.
Drugs used in this study
DrugActionConcentrationApplication method
L-AP4 Activates group III mGluRs 4 or 50 µM Bath, puffer 
BAPTA Chelates Ca2+ 10 mM Intracellular 
Cd2+ Blocks neurotransmitter release 1 mM Bath 
CGP 52432 Blocks GABAB receptors 5 µM Bath 
Concanavalin A Blocks desensitization of kainate receptors 300 µg/ml Bath 
CPPG Blocks group III mGluRs 200 or 600 µM Bath, puffer 
Cyclothiazide Blocks desensitization of AMPA receptors 60 µM Bath 
Isradipine Blocks L-type Ca2+ channels 10 µM Bath, puffer 
MK-801 Blocks NMDA receptors 1 mM Intracellular 
MMPIP Blocks mGluR7 10 µM Bath 
NMDA Activates NMDA receptors 5 mM Puffer 
Picrotoxin Blocks GABAA receptors 100 or 200 µM Bath, puffer 
SCH 23390 Blocks D1-class dopamine receptors 60 nM Bath (2–8 h) 
Spiperone Blocks D2-class dopamine receptors 60 nM Bath (2–8 h) 
Strychnine Blocks glycine receptors 5 or 10 µM Bath, puffer 
TBOA Blocks glutamate transporters 25 µM Bath 
TPMPA Blocks GABAC receptors 15 or 30 µM Bath, puffer 
DrugActionConcentrationApplication method
L-AP4 Activates group III mGluRs 4 or 50 µM Bath, puffer 
BAPTA Chelates Ca2+ 10 mM Intracellular 
Cd2+ Blocks neurotransmitter release 1 mM Bath 
CGP 52432 Blocks GABAB receptors 5 µM Bath 
Concanavalin A Blocks desensitization of kainate receptors 300 µg/ml Bath 
CPPG Blocks group III mGluRs 200 or 600 µM Bath, puffer 
Cyclothiazide Blocks desensitization of AMPA receptors 60 µM Bath 
Isradipine Blocks L-type Ca2+ channels 10 µM Bath, puffer 
MK-801 Blocks NMDA receptors 1 mM Intracellular 
MMPIP Blocks mGluR7 10 µM Bath 
NMDA Activates NMDA receptors 5 mM Puffer 
Picrotoxin Blocks GABAA receptors 100 or 200 µM Bath, puffer 
SCH 23390 Blocks D1-class dopamine receptors 60 nM Bath (2–8 h) 
Spiperone Blocks D2-class dopamine receptors 60 nM Bath (2–8 h) 
Strychnine Blocks glycine receptors 5 or 10 µM Bath, puffer 
TBOA Blocks glutamate transporters 25 µM Bath 
TPMPA Blocks GABAC receptors 15 or 30 µM Bath, puffer 

or Create an Account

Close Modal
Close Modal